MD Anderson Cancer Center — Houston, Texas

Public research footprint of MD Anderson Cancer Center, compiled from the ClinicalTrials.gov public registry.

4,826

Registered studies

1,539

Active

843

Recruiting now

2,194

Completed

891

Stopped or withdrawn

Most-studied conditions

Metastatic Non-Cutaneous Melanoma · Malignant Solid Neoplasm · PDAC - Pancreatic Ductal Adenocarcinoma · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT03528642 — Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at MD Anderson Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.